美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Aclarion Equity Warrant Exp 1st Dec 2026 Warrant

0.0258

0.0000

盤後：0.02580.00000.00%16:01 EDT

成交量：- -

成交額：- -

市值：1.50萬

市盈率：0.00

高：0.0258

開：0.0258

低：0.0258

收：0.0258

52周最高：0.1990

52周最低：0.0200

股本：58.24萬

流通股本：58.24萬

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-1,684.7590

淨資產收益率：--

總資產收益率：-116.03%

市淨率：-0.00

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

Aclarion發布最新真實世界研究：Nociscan®在診斷疼痛性腰椎間盤方面與椎間盤造影術高度一致，獲有力驗證

ACLARION, INC：2026年第三季度掃描量按年攀升85%，截至2026年9月30日止九個月增幅達117%

Aclarion手握1420萬美元現金，資金可支撐至2027年下半年並保障300名患者Clarity試驗推進

Aclarion宣佈洛杉磯首傢俬人診所加入Clarity試驗，進一步加速患者招募進程

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/ACONW/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ACONW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACONW\",,,,,undefined,":{"symbol":"ACONW","market":"US","secType":"STK","nameCN":"Aclarion Equity Warrant Exp 1st Dec 2026 Warrant","latestPrice":0.0258,"timestamp":1792785600000,"preClose":0.0258,"halted":0,"volume":0,"hourTrading":{"tag":"盘后","latestPrice":0.0258,"preClose":0.0258,"latestTime":"16:01 EDT","volume":1,"amount":0.021077,"timestamp":1792785719312,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0,"floatShares":582377,"shares":582377,"eps":-1684.759,"marketStatus":"休市中","change":0,"latestTime":"10-23 16:00:00 EDT","open":0.0258,"high":0.0258,"low":0.0258,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1684.759,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1793001600000},"marketStatusCode":7,"adr":0,"listingDate":1650600000000,"exchange":"NASDAQ","adjPreClose":0.0258,"postHourTrading":{"tag":"盘后","latestPrice":0.0258,"preClose":0.0258,"latestTime":"16:01 EDT","volume":1,"amount":0.021077,"timestamp":1792785719312,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACONW\",,,,,undefined,":{"symbol":"ACONW","floatShares":582377,"roa":"-116.03%","roe":"--","lyrEps":0,"shares":582377,"dividePrice":0,"high":0.0258,"amplitude":0,"preClose":0.0258,"low":0.0258,"week52Low":0.02,"pbRate":"-0.00","psRate":"0.25","week52High":0.199,"institutionHeld":0,"latestPrice":0.0258,"eps":-1684.759,"divideRate":0,"volume":0,"delay":0,"ttmEps":-1684.759,"open":0.0258,"prevYearClose":0.0379,"prevWeekClose":0.0275,"prevMonthClose":0.0255,"prevQuarterClose":0.0255,"fiveDayClose":0.0275,"twentyDayClose":0.0257,"sixtyDayClose":0.0243},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACONW\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACONW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ACONW\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ACONW\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1101023948","title":"Aclarion發布最新真實世界研究：Nociscan®在診斷疼痛性腰椎間盤方面與椎間盤造影術高度一致，獲有力驗證","url":"https://stock-news.laohu8.com/highlight/detail?id=1101023948","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101023948?lang=zh_tw&edition=fundamental","pubTime":"2026-10-22 19:01","pubTimestamp":1792666885,"startTime":"0","endTime":"0","summary":"Aclarion发布最新真实世界研究：Nociscan®在诊断疼痛性腰椎间盘方面与椎间盘造影术高度一致，获有力验证","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACON","BK4167","ACONW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126310081","title":"ACLARION, INC：2026年第三季度掃描量按年攀升85%，截至2026年9月30日止九個月增幅達117%","url":"https://stock-news.laohu8.com/highlight/detail?id=1126310081","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126310081?lang=zh_tw&edition=fundamental","pubTime":"2026-10-20 19:09","pubTimestamp":1792494548,"startTime":"0","endTime":"0","summary":"ACLARION, INC：2026年第三季度扫描量同比攀升85%，截至2026年9月30日止九个月增幅达117%","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACONW","BK4167","ACON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122801714","title":"Aclarion手握1420萬美元現金，資金可支撐至2027年下半年並保障300名患者Clarity試驗推進","url":"https://stock-news.laohu8.com/highlight/detail?id=1122801714","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122801714?lang=zh_tw&edition=fundamental","pubTime":"2026-10-20 19:08","pubTimestamp":1792494494,"startTime":"0","endTime":"0","summary":"Aclarion手握1420万美元现金，资金可支撑至2027年下半年并保障300名患者Clarity试验推进","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACON","BK4167","ACONW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150113711","title":"Aclarion宣佈洛杉磯首傢俬人診所加入Clarity試驗，進一步加速患者招募進程","url":"https://stock-news.laohu8.com/highlight/detail?id=1150113711","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150113711?lang=zh_tw&edition=fundamental","pubTime":"2026-05-07 18:03","pubTimestamp":1778148198,"startTime":"0","endTime":"0","summary":"医疗技术公司Aclarion, Inc近日宣布，其位于洛杉矶的首家私人执业医疗机构已正式加入Clarity临床试验项目。这一战略举措将显著推进该试验的患者入组速度，为加速获得关键临床数据奠定坚实基础。此次合作标志着Aclarion在扩大临床试验网络方面取得重要突破。Clarity试验旨在评估Aclarion专利技术在不同医疗场景中的应用效果。这一进展也反映出Aclarion正在通过多元化合作模式，系统化推进临床开发进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","ACONW","ACON"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":4,"code":"91000000","status":"200"}]}}